05.01.07
Soy Labs, LLC, Fairfield, CA, has re-ceived a grant from the Missouri Soybean Merchandising Council (MSMC) to conduct research on the cholesterol-lowering effects of Lunasin, a soy peptide. Of numerous research proposals submitted, this is one of only two new projects granted funding by the MSMC board, which is comprised of leaders in soybean research and production. Previous Lunasin research, presented last fall at the Fourth International Conference on Soy and Health (Düsseldorf, Germany), identified this chromatin-binding soy peptide as the active factor in soy protein that is responsible for the LDL cholesterol-lowering effect attributed to soy. The new study will expand on that research to investigate the potential for developing a proprietary, bioavailable ingredient called Lunasin-XP, which can be incorporated into nutraceuticals, functional foods and beverages.